Kidney360

Scope & Guideline

Transforming kidney care with impactful research.

Introduction

Welcome to your portal for understanding Kidney360, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2641-7650
PublisherAMER SOC NEPHROLOGY
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2020 to 2024
AbbreviationKIDNEY360 / Kidney360
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1401 H Street NW, Suite 900, WASHINGTON, DC 20005, UNITED STATES

Aims and Scopes

The journal 'Kidney360' focuses on advancing the understanding and management of kidney diseases through innovative research and comprehensive clinical insights. Its primary aims include exploring novel therapeutic strategies, understanding disease mechanisms, and enhancing patient care in nephrology.
  1. Kidney Disease Mechanisms:
    Research on the underlying biological and pathological mechanisms of various kidney diseases, including glomerular disorders, tubulointerstitial diseases, and systemic conditions affecting kidney function.
  2. Clinical Management and Therapeutics:
    Studies that evaluate the effectiveness of current and emerging therapies for kidney diseases, including pharmacological interventions, dialysis techniques, and transplant outcomes.
  3. Patient-Centered Outcomes:
    Research focusing on the quality of life, patient experiences, and preferences related to kidney disease management, including the impact of treatments on patient well-being.
  4. Health Disparities and Access to Care:
    Investigations into the socio-economic and racial disparities in kidney disease prevalence, treatment access, and outcomes, aiming to inform equitable healthcare practices.
  5. Global Perspectives in Nephrology:
    A focus on international practices and challenges in nephrology, including dialysis and transplantation across different healthcare systems and demographics.
  6. Innovations in Kidney Diagnostics:
    Exploration of new biomarkers, imaging techniques, and diagnostic methods to improve early detection and monitoring of kidney diseases.
The journal 'Kidney360' reflects the evolving landscape of nephrology research, with several emerging themes gaining traction in recent years. This section outlines the trending areas of focus that are increasingly prominent in the journal's publications.
  1. Impact of COVID-19 on Kidney Health:
    A significant surge in research addressing the implications of COVID-19 on kidney health, including the effects of vaccination on patients with kidney disease and the management of acute kidney injury in COVID-19 cases.
  2. Artificial Intelligence and Machine Learning:
    Emerging interest in the application of AI and machine learning techniques for predicting kidney disease outcomes, optimizing treatment protocols, and enhancing diagnostic accuracy.
  3. Patient-Centric Care Models:
    A growing emphasis on understanding patient experiences and preferences in kidney disease management, with research focusing on shared decision-making, telehealth, and patient-reported outcomes.
  4. SGLT2 Inhibitors and Cardiorenal Outcomes:
    An increasing body of literature exploring the role of SGLT2 inhibitors in treating kidney disease and their cardiovascular benefits, reflecting a broader interest in integrated therapies.
  5. Environmental Factors and Kidney Disease:
    Emerging research examining the influence of environmental factors, such as air pollution and dietary impacts, on kidney health and disease progression.
  6. Global Health Perspectives in Nephrology:
    A trend towards investigating kidney health in low- and middle-income countries, emphasizing the challenges and innovations in nephrology practice globally.

Declining or Waning

While 'Kidney360' continues to expand its focus on various aspects of nephrology, certain themes have shown a decline in prominence over recent years. This section highlights those areas that appear to be receiving less attention in the current literature.
  1. Traditional Dialysis Techniques:
    There has been a noticeable shift towards exploring novel dialysis technologies and home-based therapies, leading to a decrease in studies focused solely on conventional hemodialysis methods.
  2. Pharmacogenomics of Kidney Disease:
    Though initial interest was significant, the focus on pharmacogenomics specific to nephrology has waned, with fewer studies emerging in this area compared to other rapidly advancing topics.
  3. Basic Science Studies in Animal Models:
    Research employing animal models for basic science studies of kidney diseases has decreased, possibly due to a growing emphasis on translational research and human studies.
  4. Epidemiological Studies of Kidney Disease:
    While epidemiological studies are still relevant, there appears to be a reduction in the volume of publications exploring the epidemiology of specific kidney diseases, as more attention is directed towards clinical interventions and outcomes.

Similar Journals

International Journal of Nephrology and Renovascular Disease

Elevating nephrology: Your gateway to vital research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7058Frequency: 1 issue/year

The International Journal of Nephrology and Renovascular Disease is a prestigious peer-reviewed journal dedicated to advancing the field of nephrology and related renal research. Published by DOVE MEDICAL PRESS LTD, this open access journal has been a vital resource for the nephrology community since its inception in 2008. With a focus on innovative studies and emerging trends, the journal has established itself in the scholarly landscape, achieving an impressive Q2 ranking within the nephrology category according to the 2023 Scopus metrics, and positioning itself at rank #33 out of 81 journals in the field. The journal aims to provide a platform for both established researchers and emerging scholars to share their findings and insights, significantly contributing to improving patient outcomes and enhancing the understanding of renal health. As it continuously seeks to publish high-quality research that reflects the latest developments in the discipline, the International Journal of Nephrology and Renovascular Disease serves as an indispensable tool for anyone involved in nephrology research, clinical practice, and education.

Nature Reviews Nephrology

Shaping the future of nephrology with cutting-edge reviews.
Publisher: NATURE PORTFOLIOISSN: 1759-5061Frequency: 12 issues/year

Nature Reviews Nephrology is a prestigious academic journal published by NATURE PORTFOLIO, focusing on the rapidly evolving field of nephrology. As a leader in its category, it holds an impressive Q1 ranking in the 2023 category for Nephrology and ranks #1 out of 81 in the Scopus metrics, reflecting its high impact and relevance within the scientific community, with a staggering 99th percentile ranking. Established in 2009, this journal provides in-depth reviews, critical analysis, and cutting-edge research updates, making it an essential resource for researchers, professionals, and students alike. With an accessible Open Access policy, it enhances the dissemination of knowledge, ensuring that vital research in renal health and disease reaches a wide audience. Situated in the United Kingdom, Nature Reviews Nephrology remains committed to advancing understanding and treatment in nephrology, emphasizing the importance of this area of study in improving patient outcomes globally.

Kidney Diseases

Advancing nephrology through open access insights.
Publisher: KARGERISSN: 2296-9381Frequency: 6 issues/year

Kidney Diseases is an esteemed open-access journal published by KARGER that has been at the forefront of nephrology research since its inception in 2015. With an impressive Scopus ranking of #13 out of 81 in the field of Medicine Nephrology, placing it in the top 84th percentile, the journal has established itself as a vital resource for researchers, clinicians, and students interested in advancing knowledge on kidney health, disorders, and innovative treatment strategies. This journal aims to disseminate cutting-edge findings and clinical insights over a converged publication span from 2019 to 2024, fostering global collaboration and dialogue within the scientific community. With its commitment to open access, Kidney Diseases ensures that critical research is freely accessible, promoting wider dissemination of knowledge and the development of effective therapeutic interventions.

CLINICAL NEPHROLOGY

Transforming the landscape of kidney disease management.
Publisher: DUSTRI-VERLAG DR KARL FEISTLEISSN: 0301-0430Frequency: 12 issues/year

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.

SEMINARS IN DIALYSIS

Innovative solutions for the evolving landscape of nephrology.
Publisher: WILEYISSN: 0894-0959Frequency: 6 issues/year

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

Kidney International Reports

Unlocking knowledge for effective kidney treatments.
Publisher: ELSEVIER SCIENCE INCISSN: 2468-0249Frequency: 12 issues/year

Kidney International Reports, published by ELSEVIER SCIENCE INC, stands as a premier open-access journal in the realm of nephrology, having established itself since its inception in 2016. This scholarly platform, with an ISSN of 2468-0249, is dedicated to presenting high-quality research and critical reviews that advance our understanding of kidney health and disease. With a remarkable Q1 ranking in nephrology and a notable position within the top 10 of Scopus rankings for this specialty, the journal is a pivotal resource for researchers, healthcare professionals, and students alike. Featuring a broad scope of topics from clinical nephrology to innovative treatment strategies, Kidney International Reports ensures accessibility to the latest findings through its open access model, making it instrumental in promoting knowledge sharing and collaboration across the global nephrology community. The journal's commitment to excellence not only enhances the visibility of research but also fosters the development of effective treatments and therapies for kidney diseases.

KIDNEY & BLOOD PRESSURE RESEARCH

Innovating Nephrology and Cardiovascular Medicine.
Publisher: KARGERISSN: 1420-4096Frequency: 12 issues/year

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

Nephrologie & Therapeutique

Uniting research and practice in kidney disease management.
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1769-7255Frequency: 7 issues/year

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.

Advances in Kidney Disease and Health

Elevating Patient Outcomes with Cutting-Edge Insights
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 2949-8147Frequency: 6 issues/year

Advances in Kidney Disease and Health is a leading interdisciplinary journal that aims to bridge the gap between research and clinical practice in the field of nephrology. Published by W B SAUNDERS CO-ELSEVIER INC, this journal facilitates the dissemination of high-quality research and innovative techniques in kidney disease management, thereby enhancing patient outcomes. With an impressive Scopus ranking of #21 out of 81 in Medicine Nephrology, positioning it within the 74th percentile, this journal is an essential resource for researchers, healthcare professionals, and students devoted to uncovering the latest advancements in kidney health. As an Open Access title, it ensures that critical findings are freely available to a global audience, fostering collaboration and knowledge sharing across the nephrology community. The journal encompasses a range of topics from clinical trials to health policy, facilitating a comprehensive understanding of kidney disease and its implications on health systems. Embrace the opportunity to contribute to and engage with groundbreaking research in this pivotal field, as the journal continues its mission from 2023 to 2024 and beyond.

JOURNAL OF NEPHROLOGY

Elevating nephrology knowledge for a healthier future.
Publisher: SPRINGER HEIDELBERGISSN: 1121-8428Frequency: 9 issues/year

JOURNAL OF NEPHROLOGY is a premier academic journal dedicated to the field of nephrology, published by Springer Heidelberg. With its ISSN 1121-8428 and E-ISSN 1724-6059, this journal serves as a dynamic platform for disseminating high-quality research and groundbreaking findings in kidney health and disease. Since its inception in 1989, it has established itself as a vital resource for professionals, researchers, and students, consistently ranking in the top quartile (Q1) of nephrology journals and securing an impressive Scopus rank of #19 out of 81, placing it in the 77th percentile. Although it operates under a subscription model, the journal fosters an inclusive academic environment where critical discussions and innovative approaches to nephrological challenges are encouraged. With a commitment to advancing knowledge and practice in nephrology, JOURNAL OF NEPHROLOGY remains an essential resource for anyone who seeks to stay at the forefront of kidney research and clinical care.